Off-Label Use of Recombinant Factor VIIA Concentrates After Cardiac Surgery
- 31 July 2005
- journal article
- editorial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (1), 3-5
- https://doi.org/10.1016/j.athoracsur.2005.04.007
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Recombinant Factor VIIa in the Treatment of Postoperative Hemorrhage After Cardiac SurgeryThe Annals of Thoracic Surgery, 2005
- Recombinant Activated Factor VII for Acute Intracerebral HemorrhageNew England Journal of Medicine, 2005
- Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score–matched case‐control analysisTransfusion, 2004
- Transfusion medicine service policies for recombinant factor VIIa administrationTransfusion, 2004
- Analysis and results of the recombinant factor VIIa extended-use registryBlood Coagulation & Fibrinolysis, 2003
- Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VIIThe Journal of Thoracic and Cardiovascular Surgery, 2002
- Recurrent thrombosis of biventricular-support devices associated with accelerated intravascular coagulation and increased heparin requirementsThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Fatal aortic thrombosis in a neonate during infusion of epsilon-aminocaproic acidJournal of Pediatric Surgery, 1995
- Intracardiac thrombus: A risk of incomplete anticoagulation for cardiac operationsThe Annals of Thoracic Surgery, 1994
- Extensive Thrombus Formation With Heparin Resistance During Extracorporeal CirculationArchives of Internal Medicine, 1987